Patent · US Active

Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus

US9636324B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

CHANGZHOU UNIVERSITY · CN

Inventors

Guifu Dai · Zhengzhou, CN
Jing Zhao · Shanghai, CN
Haiwei Xu · Zhengzhou, CN
Huanfei Liu · Zhengzhou, CN
Zhenwei Wu · West Lafayette, US
Di Wu · Danbury, US
Jian WU · Zhengzhou, CN
Hongmin Liu · Zhengzhou, CN

Key dates

Filing date	Jun 8, 2016
Grant date	May 2, 2017
Priority date	—
Expiry date	Jun 8, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.